{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "62407",
      "recalling_firm": "Watson Laboratories Inc",
      "address_1": "311 Bonnie Cir",
      "address_2": "N/A",
      "postal_code": "92880-2882",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-1436-2012",
      "product_description": "Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA  92880; Distributed by: Watson Pharma, Inc., Corona, CA  92880.",
      "product_quantity": "18,938 cartons",
      "reason_for_recall": "Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.",
      "recall_initiation_date": "20120605",
      "center_classification_date": "20120801",
      "termination_date": "20130318",
      "report_date": "20120808",
      "code_info": "Lot #s: 412572A, 412572B, Exp 11/12"
    }
  ]
}